Evaluation of the Efficacy of Sex Hormone–Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS
Authors:
- 15 March 2021
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 28 (9) , 2504-2513
Abstract
This study aimed to evaluate the efficacy of SHBG in predicting insulin resistance (IR) in newly diagnosed, untreated patients with polycystic ovary syndrome (PCOS). Hundred newly diagnosed, untreated patients with PCOS and 61 subjects without PCOS (41 healthy volunteers with normal BMI and 20 subjects with overweight/obese) were included in the study. Receiver-operating characteristic (ROC) analysis was used to assess the effectiveness of SHBG in predicting IR in overweight/obese and non-overweight PCOS patients and the optimal cut-off values of SHBG. The results showed negative correlations between log-SHBG and log-I0 (r = − 0.372, P < 0.001) and log-SHBG and log-Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (r = − 0.393, P < 0.001) after adjusting for blood pressure, serum lipid, age, and body mass index (BMI) in all of the PCOS patients. In patients with IR (defined as HOMA-IR ≥2.29), the area under the ROC curves (AUCs) of the SHBG for ROC analysis in the non-overweight group, overweight/obese group, and all PCOS patients were 0.774 (P = 0.0001), 0.922 (P = 0.0001), and 0.885 (P = 0.0001), respectively. The optimal cut-off value of SHBG was 37 nmol/L with a sensitivity of 97.62% and specificity of 80.85% in the overweight group. In patients with IR (HOMA-IR ≥2.5), the AUCs of SHBG for ROC analysis in the non-overweight group, overweight/obese group, and all PCOS patients were 0.741 (P = 0.0003), 0.928 (P = 0.0001), and 0.880 (P = 0.0001), respectively. The optimal cut-off value of SHBG was 30.2 nmol/L with a sensitivity of 97.44% and specificity of 82.69% in the overweight/obese group. In conclusion, this study observed a negative correlation between SHBG and HOMA-IR in PCOS patients after adjustment of confounding factors. SHBG was an independent influential factor of HOMA-IR and can be used as a positive predictive marker for IR in PCOS patients, especially in those who are overweight/obese.Keywords
Funding Information
- National Natural Science Foundation of China (81200619)
- Medical Scientific Research Foundation of Guangdong Province (A2020390)
This publication has 28 references indexed in Scilit:
- Inverse association between serum insulin and sex hormone-binding globulin in a population survey in SwedenEndocrine Connections, 2013
- The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysisObesity Reviews, 2012
- Association of Testosterone and Sex Hormone–Binding Globulin With Metabolic Syndrome and Insulin Resistance in MenDiabetes Care, 2010
- Surrogate markers of insulin resistance: A reviewWorld Journal of Diabetes, 2010
- Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndromeEuropean Journal of Endocrinology, 2007
- Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndromeFertility and Sterility, 2006
- Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndromeFertility and Sterility, 2006
- Insulin Sensitivity Indices: a Proposal of Cut-Off Points for Simple Identification of Insulin-Resistant SubjectsExperimental and Clinical Endocrinology & Diabetes, 2006
- Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled studyHuman Reproduction, 2005
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985